1. Home
  2. LSTA vs WKHS Comparison

LSTA vs WKHS Comparison

Compare LSTA & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • WKHS
  • Stock Information
  • Founded
  • LSTA 1980
  • WKHS 2007
  • Country
  • LSTA United States
  • WKHS United States
  • Employees
  • LSTA N/A
  • WKHS N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • WKHS Auto Manufacturing
  • Sector
  • LSTA Health Care
  • WKHS Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • WKHS Nasdaq
  • Market Cap
  • LSTA 22.5M
  • WKHS 26.6M
  • IPO Year
  • LSTA N/A
  • WKHS N/A
  • Fundamental
  • Price
  • LSTA $2.69
  • WKHS $1.94
  • Analyst Decision
  • LSTA Strong Buy
  • WKHS Hold
  • Analyst Count
  • LSTA 2
  • WKHS 1
  • Target Price
  • LSTA $23.50
  • WKHS $15.62
  • AVG Volume (30 Days)
  • LSTA 56.3K
  • WKHS 8.8M
  • Earning Date
  • LSTA 08-11-2025
  • WKHS 08-19-2025
  • Dividend Yield
  • LSTA N/A
  • WKHS N/A
  • EPS Growth
  • LSTA N/A
  • WKHS N/A
  • EPS
  • LSTA N/A
  • WKHS N/A
  • Revenue
  • LSTA $1,000,000.00
  • WKHS $5,917,985.00
  • Revenue This Year
  • LSTA N/A
  • WKHS $54.16
  • Revenue Next Year
  • LSTA N/A
  • WKHS $85.00
  • P/E Ratio
  • LSTA N/A
  • WKHS N/A
  • Revenue Growth
  • LSTA N/A
  • WKHS N/A
  • 52 Week Low
  • LSTA $1.87
  • WKHS $0.81
  • 52 Week High
  • LSTA $4.20
  • WKHS $24.25
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 52.66
  • WKHS 50.36
  • Support Level
  • LSTA $2.45
  • WKHS $1.94
  • Resistance Level
  • LSTA $2.74
  • WKHS $2.33
  • Average True Range (ATR)
  • LSTA 0.27
  • WKHS 0.72
  • MACD
  • LSTA -0.00
  • WKHS -0.09
  • Stochastic Oscillator
  • LSTA 51.81
  • WKHS 3.65

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

Share on Social Networks: